Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression analysis of normal mammary gland fibroblasts (NFs) and cancer-associated fibroblasts (CAFs) from the murine breast cancer model MMTV-PyMT after perturbing the expression of Hsp90aa1 and Hsp90ab1 by RNAi

ABSTRACT: Cancers adapt proteostasis to cope with the burden of misfolded proteins, stabilize key signalling nodes and sustain their malignant behaviour. Tumour stroma is subjected to similar stresses, but how they influence its aberrant status remains unclear. We show that tumour stroma presents consistent upregulation of target genes associated to the major misfolding regulator HSP90 in cancer-associated fibroblasts (CAFs), and that HSP90α is required for CAFs to remodel the extracellular matrix (ECM) and promote cancer cell motility and growth. Mechanistically, HSP90α sustains TGFβ responses and YAP protein levels required for CAF functionality. In vivo, stromal or fibroblast-specific loss of HSP90α results in reduced ECM deposition, angiogenesis, growth and dissemination of breast tumours. Clinical analyses reveal a correlation between HSP90-dependent programs and YAP activity in CAFs, that are also associated with poor patient prognosis. Our findings uncover a link between proteostasis, mechanotransduction and generation of aggressive tumour microenvironments through HSP90α.

ORGANISM(S): Mus musculus

PROVIDER: GSE296064 | GEO | 2026/04/30

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

MiRNA expression analysis of cancer-associated fibroblasts (CAFs) and normal fibroblasts (NFs) in breast cancer

Project description:To identify miRNA differentially expressed in CAFs vs matched NFs and analyze the heterogeneity of miRNA expression profiles in the two kinds of cells, we established primary cultures of CAFs and paired NFs from six resected breast tumor tissue without any radiotherapy and chemotherapy treatment. Paired CAFs and NFs from six primary human breast carcinoma specimens were cultured,the third passage of primary cells was used in the experiments.

2012-09-28 | E-GEOD-37527 | biostudies-arrayexpress

Gene expression profiles of oral normal fibroblasts (NFs) and oral carcinoma-associated fibroblasts (CAFs)

Project description:This study aims to identify genes differentially expressed in oral CAFs with respect to their normal counterparts, i.e. oral NFs. We collected oral normal mucosal tissues and oral squamous cell carcinoma (OSCC) tissues from 12 healthy people and 12 OSCC patients, respectively, at West China Hospital of Stomatology, Sichuang University, P. R. China. The tissues were isolated, cultured and purified using standard protocols to obtain oral NFs and CAFs. Agilent 4×44K Whole Genome Oligo Microarrays were used to measure the gene expression profiles of the samples. Sample preparation and hybrid reactions were performed according to the manufacture’s instructions. RNA samples from NFs and CAFs were pooled respectively before hybridization. The chips were scanned and visualized using the Agilent DNA microarray scanner. Probe set intensities were measured using Agilent Feature Extraction software (version 10.5.1.1). Raw data were normalized in the Agilent GeneSpring GX software (version 11.0) using the Agilent FE one-color scenario (mainly median normalization). Oral NFs and CAFs were obtained from tissues derived from 12 healthy people undergoing plastic surgery and 12 OSCC patiens undergoing surgical resection. RNA samples from NFs and CAFs were pooled respectively before hybridization.

2012-01-26 | E-GEOD-35356 | biostudies-arrayexpress

Expression data from human normal fibroblasts (NFs) and cancer associated fibroblasts (CAFs)

Project description:CAFs are the major regulators in tumor microenviroment which promote cancer progression. We want to know which miRNAs changed in human CAFs compared to NFs. We used microarrays to detail the mature miRNA expression and identified distinct classes of 2-fold changed miRNAs during this process.

2022-03-28 | GSE128972 | GEO

Proteomic analysis of ECM-enriched fraction of breast xenograft and skin tissue from mice injected with 13C-glutamine

Project description:Elevated production of collagen-rich extracellular matrix (ECM) is a hallmark of cancer associated fibroblasts (CAFs) and a central driver of cancer aggressiveness. How to target ECM production to oppose cancer is yet unclear, since targeting CAFs has been shown to restrain but also promote cancer progression. Metabolic rewiring is a second hallmark of CAFs. Here we find that proline, which is a highly abundant amino acid in collagen proteins, is newly synthesised from glutamine to make tumour collagen in breast cancer xenografts, and that its production is increased in breast cancer patient-derived CAFs compared to their matched normal fibroblasts in vitro. PYCR1 is the rate-limiting enzyme for proline synthesis and is highly expressed in the tumour stroma of breast cancer patients and in CAFs. Reducing PYCR1 levels in CAFs is sufficient to reduce collagen production, tumour growth and metastatic spread in vivo and cancer cell proliferation in vitro. Collagen and proline synthesis are enhanced by increased acetyl-CoA levels, which occurs through the epigenetic regulator EP300, and targeting PYCR1 overwrites this epigenetic reprogramming and decreases collagen production. Altogether, we present a previously uncharacterised pathway that supports pro-tumorigenic collagen production in CAFs. We show that PYCR1 and COL1A1 are overexpressed in patients with poor prognosis in several cancer types. PYCR1 is a recognised cancer cell vulnerability and potential target for therapy, hence, our work provides evidence that targeting PYCR1 in tumours may have the additional benefit of halting the production of pro-tumorigenic ECM. Finally, PYCR1 is highly expressed in collagen-producing fibroblasts derived from lungs of idiopathic pulmonary fibrosis patients, suggesting that PYCR1 may also offer therapeutic opportunities in fibrotic diseases.

2022-05-31 | PXD024746 | Pride

Expression data from human normal fibroblasts (NFs) and cancer associated fibroblasts (CAFs) [HTA-2_0]

Project description:CAFs are the major regulators in tumor microenviroment which promote cancer progression. We want to know which mRNAs changed in human CAFs compared to NFs. We used microarrays to detail the mature mRNA expression and identified distinct classes of 2-fold changed mRNAs during this process.

2023-05-01 | GSE149927 | GEO

Epigenetic analysis of murine normal mammary gland fibroblasts (mNFs) and MMTV-PyMT cancer-associated fibroblasts (mCAF1) (H3K27ac ChIP-seq)

Project description:In comparison with normal tissue fibroblast (normal fibroblasts, NFs), cancer-associated fibroblasts (CAFs) have pathologically activated phenotypes that impact in a wide variety of tumoral processes including cancer cell growth and invasion, extracellular matrix (ECM) remodelling, angiogenesis and immune suppression. These phenotypes result from the establishment of altered gene expression programs that may be further sustained through epigenetic alterations. However, how epigenetic rearrangements influence CAF behaviour is not well delineated. Here, we identify aspartoacylase (ASPA) as a metabolic enzyme consistently repressed in tumour stroma and CAFs. We report a reciprocal crosstalk between ASPA and Transforming Growth Factor Beta (TGFβ) signalling that influences fibroblast behaviour. TGFβ suppresses ASPA expression in fibroblasts, whereas ASPA restrains TGFβ-dependent myofibroblast conversion, ECM remodelling, angiogenesis and pro-tumoral macrophage phenotypes. TGFβ/SMAD3-dependent transcriptional repression may require the activity of histone deacetylases (HDACs), which participate in epigenetic rearrangements modulating gene expression. Epigenomic analysis of the 3’ regulatory regions at the Aspa locus in murine MMTV-PyMT-derived breast cancer CAFs (mCAF1) as compared to normal murine mammary gland fibroblasts (mNFs), revealed a selective loss of H3K27Ac, an epigenetic mark of active enhancers. As expected, bona fide CAF marker genes such as Acta2, Fap, Lrrc15 and others presented increased H3K27Ac signal at regulatory regions in mCAF1, whereas peaks at NF marker genes (Cxcl1 and Pi16) were decreased. Our findings unveil ASPA expression in fibroblasts as a previously unknown gatekeeper of TGFβ responses and activation in cancer progression.

2026-04-09 | GSE327372 | GEO

MiRNA expression analysis of cancer-associated fibroblasts (CAFs) and normal fibroblasts (NFs) in breast cancer

2012-09-28 | GSE37527 | GEO

The role and function of YAP in cancer-associated fibroblasts

Project description:To investigate how YAP activity contributes to the functional properties of cancer-associated fibroblasts (CAFs), we established YAP-deficient cancer-associated fibroblast cell line, in which YAP expression can be inducibly silenced using shRNA, for RNA-Seq compared to wildtype CAFs.

2024-02-01 | GSE208058 | GEO

Helicobacter pylori cagA+ induces cancer-associated fibroblasts proliferation and migration in vitro

Project description:Biliary fibrosis has the effect on biliary tract contribution to cholangiocarcinoma (CCA). Activated myofibroblast accompanying cancer-associated fibroblasts (CAFs) are the abundant in tumor stroma of CCA development and plays an important for tumor microenvironment. Although Helicobacter pylori infection is known risk for CCA, the interaction of CAFs and H. pylori is unclear. This study aimed to demonstrate the effect of H. pylori on the tumorigenesis and progression of the CAFs cell in vitro.

2024-05-10 | PXD042124 | JPOST Repository

Gene expression profiles of oral normal fibroblasts (NFs) and oral carcinoma-associated fibroblasts (CAFs)

2012-01-26 | GSE35356 | GEO